DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Firms / P•••••• H••••••••• M• 2••• L••
P•••••• H••••••••• M• 2••• L••
Institutional venture firm · probableHerzliyap••••••.comSEC exempt reporting adviseremerging managerpart of P•••••• V•
One of 5 advisers that share p••••••.com; the firm is P•••••• V•. P•••••• I••••••••• M• 2••• L•••, P•••••• H•••••••••, P•••••• V•••••• C••••••, P•••••• V•••••• P••••••• 2••• L•••. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
venture manager, reported GAV $93M across 2 vehicles
Importance
21
moderate
Active deployment
29
moderate
Emerging
69
high
Completeness
63
high
Freshness
95
high
Research priority
29
moderate
Identity and regulatory footprint
- Headquarters
- Herzliya, Israeladviserinfo.sec.gov
- Office address
- ••• Lockedadviserinfo.sec.gov
- Business phone
- ••• Lockedadviserinfo.sec.gov
- Website
- p••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- Aug 7, 2024
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $92.6Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- R•• V••••••• I••••••••• 2••• L••• (Shareholder), A; 6• V••••••• 2••• L••• (Shareholder), A; S••••• 2•••• L••• (Shareholder), B; P•••• V••••••• I••••••••• 2••• L••• (Shareholder), A; S•••• V••••••• L••• (Shareholder), A; A••• V••••••• L••• (Shareholder), A; L••• E••• N•• L••• (Shareholder), A
- business phone
- 972 9 9718100adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
3 observed deals
Stated (the firm’s website)
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
Pharmaceuticals 33%Other Technology 33%Other Health Care 33%
lead rate n/afollow-on rate n/anew logos, 12 months 1
Funds and vehicles
2 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| P•••••• H••••••••• F••• I•• L••• | Fund | 2023 form d first sale | Active deployment | $90.5M Aug 7, 2024 | 24 | $111M | Nov 6, 2024 |
| P•••••• H••••••••• P••••••••• F••• I•• L••• | Feeder or parallel | unknown | Unknown | $2.0M Aug 7, 2024 | 8 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
9 current, 0 departed
A•••• M••••••••
PartnerManaging Director · since Dec 1, 2022
A••• I••••••••
PartnerManaging Director · since Dec 1, 2022
E••• N••
PartnerManaging Director · since Dec 1, 2022
H••• K••••
PartnerShareholder And Managing Director · since Dec 1, 2022
I•••• H•••••
PartnerManaging Director · since Dec 1, 2022
I•••• H••••
PartnerShareholder And Managing Director · since Dec 1, 2022
N••••••• P••••
PartnerManaging Director · since Dec 1, 2022
R••• K•••••
PartnerManaging Director · since Dec 1, 2022
E••• K••••
Platform and operationsCfo · since Jul 1, 2023
Investments on record
3 edges, 3 companies, 3 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| A••••• B••••••••• I••• | board seat | unknown · board | I•••• H•••• (strongly supported) | unknown | unknown | Feb 23, 2026 | Inference SEC EDGAR Form D data sets (quarterly) |
| H••••••••• I••• | board seat | unknown · board | I•••• H•••• (strongly supported) | unknown | unknown | Aug 27, 2024 | Inference SEC EDGAR Form D data sets (quarterly) |
| D••••••••• C•••• | board seat | unknown · board | H••• K•••• (strongly supported) | unknown | unknown | Feb 29, 2024 | Inference SEC EDGAR Form D data sets (quarterly) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
4 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
4 dated events
- Mar 28, 2024P•••••• H••••••••• M• 2••• L•• first filed Form ADV (ERA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2024P•••••• H••••••••• P••••••••• F••• I•• L••• first reported on Form ADV by P•••••• H••••••••• M• 2••• L•• (Venture Capital Fund), GAV $2,046,000Fund first reported on Form ADVFundsFactP•••••• H••••••••• P••••••••• F••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2024P•••••• H••••••••• F••• I•• L••• first reported on Form ADV by P•••••• H••••••••• M• 2••• L•• (Venture Capital Fund), GAV $90,537,000Fund first reported on Form ADVFundsFactP•••••• H••••••••• F••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 1, 2023E••• K•••• joined Schedule A of P•••••• H••••••••• M• 2••• L•• as Cfo
Classification history
- Sep 12, 2026Institutional venture firm (probable, 80%, cls-1)venture manager, reported GAV $93M across 2 vehicles
Evidence
16 observations from 1 source